Skip to main content
SSY Group Limited logo

SSY Group Limited — Investor Relations & Filings

Ticker · 2005 ISIN · KYG8406X1034 HKEX Manufacturing
Open in API
Filings indexed 1,213 across all filing types
Latest filing 2025-03-03 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2005

About SSY Group Limited

http://www.ssygroup.com.hk

SSY Group Limited is an investment holding company specializing in the research, development, manufacturing, and sale of pharmaceutical products. The Group is a prominent manufacturer, with a core focus on producing a wide range of intravenous infusion solutions and finished drugs. Complementing its pharmaceutical offerings, the company also manufactures essential packaging materials, including non-PVC soft bags and PP plastic containers. SSY Group supplies its comprehensive product line, which often utilizes green production technologies aimed at reducing costs and power consumption, primarily to hospitals and medical institutions.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings Classification · 78% confidence The document is a mandatory Monthly Return filed to the Hong Kong Stock Exchange under Chapter 19B, detailing movements in authorized and issued share capital, share options, repurchases and other share-related activities for the month. It is a regulatory filing rather than a standalone report like an annual report, earnings release or specific share transaction notice. There is no bespoke category for a periodic return of movements in securities, so it falls into the fallback category of general regulatory announcements. Therefore it is classified as a Regulatory Filing (RNS).
2025-03-03 English
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Regulatory Filings Classification · 65% confidence The document is a voluntary Hong Kong Stock Exchange announcement by SSY Group Limited regarding regulatory approvals for new drug products. It does not report financial results, changes in management, dividends, share issues, or other specific categories. It is not the full report itself but a routine corporate announcement of business development. It falls into the fallback category for miscellaneous regulatory filings.
2025-02-25 English
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Regulatory Filings Classification · 85% confidence The document is a Hong Kong Stock Exchange voluntary announcement updating investors on product development (“Piribedil has obtained the approval for registration…”). It contains no financial results, no meeting materials, not a full report, and no specified category match (e.g., earnings, M&A, dividends). Therefore it falls under the fallback category for miscellaneous regulatory announcements: Regulatory Filings (RNS).
2025-02-24 English
Next Day Disclosure Return - Changes in issued shares
Transaction in Own Shares Classification · 95% confidence The document is a Next Day Disclosure Return (FF305) filed under Hong Kong Listing Rules, detailing multiple share repurchases and cancellations by SSY Group Limited. It is not a full financial report or AGM material but a statutory disclosure of the company’s own share buyback transactions. This falls squarely under “Transaction in Own Shares” (POS).
2025-02-05 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change Classification · 82% confidence The document is an FF301 monthly return filed with the Hong Kong Exchange detailing movements in authorised share capital, issuance, share options activity, treasury shares and share repurchases for SSY Group Limited. It is not an earnings release or AGM material but a mandatory regulatory submission concerning share capital changes. Accordingly, it falls under Share Issue/Capital Change (SHA).
2025-02-03 English
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Regulatory Filings Classification · 80% confidence The document is a voluntary announcement by SSY Group Limited regarding product development updates (drug approvals) made on the Hong Kong Exchange. It contains no financial statements or operational results, nor is it a presentation, proxy, or board change notice. It is not announcing the publication of a separate report, nor fitting any specific category like M&A, dividends, or insider dealings. This falls into the miscellaneous regulatory announcement catch-all category ‘Regulatory Filings’ (RNS).
2025-01-20 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.